News	Events
Publications	Companies
Clinical Trials

Tag Archives: microRNA therapeutics

• Mirna Therapeutics Secures $34.5 Million Series C Financing to Advance Oncology microRNA Pipeline into the Clinic

  0 Replies
  

  October 24, 2012

  Institutional Investment Is One of the Largest Ever for a Texas Biotechnology Company Austin, TX – October 24, 2012 Mirna Therapeutics Inc. (Mirna), a biopharmaceutical company focused on the development and commercialization of microRNA (miRNA) therapeutics in cancer, announced today the completion of a $34.5 million Series C financing. The... Contine Reading & Discuss→

• Silence Therapeutics signs collaboration with Mirna Therapeutics to evaluate delivery of novel microRNA therapeutics

  1 Reply
  

  October 24, 2011

  --Collaboration to investigate potential application of Silence’s novel AtuPLEX™ and DBTC delivery technologies in the development of novel microRNA therapeutics targeting cancer -- London, UK October XX, 2011 –Silence Therapeutics plc (AIM: SLN) (“Silence”), a leading RNA interference (RNAi) therapeutics company, today announced that it has entered into an agreement... Contine Reading & Discuss→

• Silence Therapeutics and InteRNA Technologies sign collaboration to develop novel microRNA therapeutics

  0 Replies
  

  September 30, 2011

  -- Collaboration to investigate potential of AtuPLEX™ in the development of novel microRNA therapeutics targeting cancer -- London, UK & Nijmegen/Utrecht, Netherlands, September 12, 2011 –Silence Therapeutics plc (AIM: SLN) (“Silence”), a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V. (“InteRNA”), a biopharmaceutical company developing pathway targeted... Contine Reading & Discuss→